DV
Dividend Vision

ASRT — Assertio Holdings, Inc.

No longer trading. This fund has been liquidated; the figures below are frozen at its final trading day.

Assertio Holdings, Inc. (ASRT)

Assertio Holdings is a specialty pharmaceutical company that commercializes branded medicines across neurology, oncology, and pain and inflammation therapeutic areas. As an individual equity security rather than a diversified fund, it does not have a distribution rate, expense ratio, or fund-level characteristics typical of ETFs. The stock may appeal to healthcare investors seeking exposure to pharmaceutical development and commercialization, though it carries company-specific risks inherent to individual equities. Trading ceased after 06/29/2026; the shares last closed at $23.50. No later quote reflects a live market.

ASRT key facts

Asset type
Stock
Asset class
Equity
Inception date
12/02/1997
Distribution frequency
None
Last close
$23.50
Market cap
$151,861,232
Average volume
322528.0
Beta
0.531
Payout ratio
0.0
Forward P/E
9.1085
EPS
$-5.55